Trademark: 90779841
Status Date
Tuesday, July 11, 2023
Registration Number
7102820
Registration Date
Tuesday, July 11, 2023
Filing Date
Thursday, June 17, 2021
Published for Opposition
Tuesday, February 14, 2023
5 Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
44 Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
42 Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Jul 11, 2023
Notice Of Registration Confirmation Emailed
Jul 11, 2023
Registered-Principal Register
Jun 8, 2023
1(B) Basis Deleted; Proceed To Registration
Apr 14, 2023
Notice Of Allowance Cancelled
Jun 1, 2023
Case Assigned To Intent To Use Paralegal
Apr 14, 2023
Teas Delete 1(B) Basis Received
Apr 11, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 14, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2023
Published For Opposition
Jan 25, 2023
Notification Of Notice Of Publication E-Mailed
Jan 12, 2023
Approved For Pub - Principal Register
Jan 9, 2023
Teas/Email Correspondence Entered
Jan 9, 2023
Correspondence Received In Law Office
Jan 9, 2023
Teas Response To Office Action Received
Nov 14, 2022
Notification Of Non-Final Action E-Mailed
Nov 14, 2022
Non-Final Action E-Mailed
Nov 14, 2022
Non-Final Action Written
Nov 3, 2022
Previous Allowance Count Withdrawn
Sep 20, 2022
Withdrawn From Pub - Og Review Query
Sep 7, 2022
Electronic Record Review Complete
Sep 2, 2022
On Hold - Electronic Record Review Required
Aug 30, 2022
Approved For Pub - Principal Register
Aug 10, 2022
Suspension Checked ¿ To Attorney For Action
Jul 26, 2022
Teas Response To Suspension Inquiry Received
Jul 20, 2022
Teas Change Of Correspondence Received
Jul 20, 2022
Teas Change Of Domestic Representatives Address
Jul 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 10, 2022
Notification Of Letter Of Suspension E-Mailed
Feb 10, 2022
Letter Of Suspension E-Mailed
Feb 10, 2022
Suspension Letter Written
Feb 8, 2022
Assigned To Examiner
Sep 3, 2021
New Application Office Supplied Data Entered
Jun 21, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
